Literature DB >> 18087636

Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.

Yu-Huai Ho1, Lih-Shinn Wang, Hui-Jen Chao, Kia-Chich Chang, Chain-Fa Su.   

Abstract

Multidrug-resistant Acinetobacter baumannii is an emergent nosocomial pathogen. A 61-year-old woman developed meningitis caused by MDRAB 27 days after receiving a surgical intervention for invasive meningioma. The patient failed to respond to high doses of meropenem and sulbactam treatment and the organism persisted in the cerebrospinal fluids for two months. The regimen was changed to intravenous and intrathecal colistin for 28 days and the patient responded well. Administration of colistin both intravenously and intrathecally could be a suitable option as a salvage therapy for meningitis due to multidrug-resistant A. baumannii.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18087636

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN： 1684-1182            Impact factor:   4.399


  9 in total

Review 1.  Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria.

Authors:  Rick Dersch; E Robinson; L Beume; S Rauer; W-D Niesen
Journal:  Neurol Sci       Date:  2014-12-11       Impact factor: 3.307

Review 2.  Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.

Authors:  O Bargiacchi; A Rossati; P Car; D Brustia; R Brondolo; F Rosa; P L Garavelli; F G De Rosa
Journal:  Infection       Date:  2014-04-12       Impact factor: 3.553

Review 3.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

4.  Successful management of nosocomial ventriculitis and meningitis caused by extensively drug-resistant Acinetobacter baumannii in Austria.

Authors:  M Hoenigl; M Drescher; G Feierl; T Valentin; G Zarfel; K Seeber; R Krause; Aj Grisold
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 5.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

6.  Post-neurosurgical meningitis caused by acinetobacter baumannii: case series and review of the literature.

Authors:  Shunlan Ni; Shanshan Li; Naibin Yang; Sainan Zhang; Danping Hu; Qian Li; Mingqin Lu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Successful treatment of multicompartmental cerebral ventriculitis caused by Acinetobacter baumanii.

Authors:  Dom Mahoney; David Porter; Mahableshwar Albur
Journal:  IDCases       Date:  2017-11-21

8.  Cerebrospinal Fluid Lactate as a Prognostic Indicator in Postneurosurgical Bacterial Meningitis and Use of Intrathecal Colistin.

Authors:  Pradeepkumar Hiremath; Pradeep Rangappa; Ipe Jacob; Karthik Rao
Journal:  Indian J Crit Care Med       Date:  2018-04

9.  Risk factors of multidrug-resistant Acinetobacter baumannii recurrence after successful eradication in ventilated patients.

Authors:  Chiung-Yu Lin; Yu-Mu Chen; Meng-Chih Lin; Yu-Ping Chang; Tung-Ying Chao; Chin-Chou Wang; Yuh-Chyn Tsai; Lien Shi Shen; Chin-Ling Li; An-Shen Lin
Journal:  Biomed J       Date:  2016-06-10       Impact factor: 4.910
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.